Literature DB >> 12930048

Medication misuse in hospitalized patients with renal impairment.

L Salomon1, G Deray, M C Jaudon, C Chebassier, P Bossi, V Launay-Vacher, B Diquet, J M Ceza, S Levu, G Brücker, P Ravaud.   

Abstract

OBJECTIVES: The potential consequences of medication misuse in renal impairment have not been assessed in a population of in-patients. The purpose of this study was to determine the frequency and potential consequences of a lack of dosage adjustment in hospitalized patients with renal impairment.
DESIGN: Order sheets for in-patients having a creatinine above 0.7 mg/dl were analysed. We considered the appropriateness of prescriptions for medications having potential nephrotoxicity and/or eliminated through renal excretion or metabolism (TEM medications) and having manufacturer's guidelines for dosage adjustment in renal impairment. MAIN MEASURES: On the basis of these guidelines, each line of prescription was rated as 'appropriate order', 'inappropriate dosage', or 'contra-indicated order'. Experts also rated prescriptions as potentially fatal or severe, serious, significant, or without potential for increased adverse effects.
RESULTS: Two hundred and two order sheets were completed for 164 patients. They totalled 1469 lines of prescription, 85% of which were TEM medications, with guidelines for dosage adjustment for 71% of them (n = 886). Of these 886 prescriptions, 34% were inappropriate, 14% being contra-indicated and 20% with inappropriate dosage given the patient's renal function. Among the 202 order sheets, 75% included at least one inappropriate prescription. Sixty-three per cent included at least one prescription with potentially adverse consequences, 3% of these having potentially fatal or severe consequences.
CONCLUSION: This study confirms that physicians do not take into account sufficiently patient renal function when prescribing. In light of these results, improving the quality of drug prescription in patients with renal impairment could be of importance for improving the quality of care.

Entities:  

Mesh:

Year:  2003        PMID: 12930048     DOI: 10.1093/intqhc/mzg046

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  29 in total

1.  Assessing general practitioners' prescribing behaviour in elderly patients with concealed renal failure.

Authors:  Annie Pierre Jonville-Béra; Lucie Paroux; Elisabeth Autret-Leca
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

2.  Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency.

Authors:  Terry S Field; Paula Rochon; Monica Lee; Linda Gavendo; Joann L Baril; Jerry H Gurwitz
Journal:  J Am Med Inform Assoc       Date:  2009-04-23       Impact factor: 4.497

Review 3.  Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity.

Authors:  Melissa Martin; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

4.  Electronic screening of medical records to detect inpatients at risk of drug-related problems.

Authors:  Isabelle Roten; Stefan Marty; Johnny Beney
Journal:  Pharm World Sci       Date:  2009-12-10

5.  Prescription errors in geriatric patients can be avoided by means of a computerized physician order entry (CPOE).

Authors:  S Frisse; G Röhrig; J Franklin; M C Polidori; R-J Schulz
Journal:  Z Gerontol Geriatr       Date:  2015-06-11       Impact factor: 1.281

6.  Effectiveness of pharmacist intervention in patients with chronic kidney disease.

Authors:  Aurelio Cabello-Muriel; Juan José Gascón-Cánovas; Elena Urbieta-Sanz; Carles Iniesta-Navalón
Journal:  Int J Clin Pharm       Date:  2014-08-20

7.  Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency.

Authors:  Elodie Sellier; Isabelle Colombet; Brigitte Sabatier; Gaelle Breton; Julie Nies; Eric Zapletal; Jean-Benoit Arlet; Dominique Somme; Pierre Durieux
Journal:  J Am Med Inform Assoc       Date:  2008-12-11       Impact factor: 4.497

8.  Adverse drug events during AKI and its recovery.

Authors:  Zachary L Cox; Allison B McCoy; Michael E Matheny; Gautam Bhave; Neeraja B Peterson; Edward D Siew; Julia Lewis; Ioana Danciu; Aihua Bian; Ayumi Shintani; T Alp Ikizler; Erin B Neal; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

9.  Use of renal risk drugs in patients with renal impairment.

Authors:  Hilde Holm; Kirsti Bjerke; Lone Holst; Liv Mathiesen
Journal:  Int J Clin Pharm       Date:  2015-08-18

10.  Chronology of prescribing error during the hospital stay and prediction of pharmacist's alerts overriding: a prospective analysis.

Authors:  Thibaut Caruba; Isabelle Colombet; Florence Gillaizeau; Vanida Bruni; Virginie Korb; Patrice Prognon; Dominique Bégué; Pierre Durieux; Brigitte Sabatier
Journal:  BMC Health Serv Res       Date:  2010-01-12       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.